This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

Designed by European Vaccine Initiative

Services do NOT include

Fill and finish.

Possible Output

A GMP documented and QA released antigen to be used in vaccine formulation.

Sample Requirements - input of users

Aminoacid sequence and requirements for antigen characteristics, (folding, size, aggregation).

Lead Scientist

Charlotte Green Jensen

Description of service

GMP production of recombinant vaccine candidates for clinical trials phase I/II. SSI offers Manufacture of GMP master/working cell banks and manufacture of clinical-grade vaccine candidate (drug substance).

Timeline 

12 months

GMP production services of recombinant vaccine candidates for clinical trials phase I/II

Paid Service

Contact 

Charlotte Green Jensen

CGJ@ssi.dk

0045 32683963